Embry Holdings 将来の成長

このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Embry Holdings は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。

シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。

業績と収益の成長予測

SEHK:1388 - アナリストの将来予測と過去の財務データ ( )HKD Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
6/30/2024	1,204	-160	-56	-44	N/A
3/31/2024	1,243	-116	-23	-3	N/A
12/31/2023	1,282	-72	10	38	N/A
9/30/2023	1,292	-60	53	85	N/A
6/30/2023	1,301	-47	95	133	N/A
3/31/2023	1,318	-49	109	139	N/A
12/31/2022	1,334	-51	124	145	N/A
9/30/2022	1,419	-55	139	155	N/A
6/30/2022	1,504	-59	154	166	N/A
3/31/2022	1,578	-43	157	168	N/A
12/31/2021	1,652	-27	160	171	N/A
9/30/2021	1,705	21	226	241	N/A
6/30/2021	1,757	69	291	310	N/A
3/31/2021	1,704	33	347	374	N/A
12/31/2020	1,650	-3	402	438	N/A
9/30/2020	1,751	-14	332	384	N/A
6/30/2020	1,852	-26	262	331	N/A
3/31/2020	2,060	27	168	260	N/A
12/31/2019	2,267	80	75	189	N/A
9/30/2019	2,282	91	-51	107	N/A
6/30/2019	2,297	102	-177	25	N/A
3/31/2019	2,374	127	-131	84	N/A
12/31/2018	2,452	151	-86	143	N/A
9/30/2018	2,481	337	41	214	N/A
6/30/2018	2,511	523	168	286	N/A
3/31/2018	2,425	509	N/A	227	N/A
12/31/2017	2,340	495	N/A	169	N/A
9/30/2017	2,282	296	N/A	188	N/A
6/30/2017	2,224	97	N/A	207	N/A
3/31/2017	2,220	98	N/A	204	N/A
12/31/2016	2,216	98	N/A	202	N/A
9/30/2016	2,268	122	N/A	197	N/A
6/30/2016	2,319	146	N/A	192	N/A
3/31/2016	2,427	174	N/A	190	N/A
12/31/2015	2,536	202	N/A	187	N/A
9/30/2015	2,536	205	N/A	164	N/A
6/30/2015	2,536	209	N/A	141	N/A
3/31/2015	2,460	198	N/A	138	N/A
12/31/2014	2,383	188	N/A	134	N/A
9/30/2014	2,360	194	N/A	158	N/A
6/30/2014	2,338	199	N/A	182	N/A
3/31/2014	2,286	199	N/A	222	N/A
12/31/2013	2,235	198	N/A	263	N/A

アナリストによる今後の成長予測

収入対貯蓄率: 1388の予測収益成長が貯蓄率 ( 2.3% ) を上回っているかどうかを判断するにはデータが不十分です。

収益対市場: 1388の収益がHong Kong市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です

高成長収益: 1388の収益が今後 3 年間で大幅に増加すると予想されるかどうかを判断するにはデータが不十分です。

収益対市場: 1388の収益がHong Kong市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。

高い収益成長: 1388の収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: 1388の自己資本利益率が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です

Embry Holdings 将来の成長

Future 基準チェック /06

主要情報

今後の成長に関する最新情報

Embry Holdings Limited Provides Unaudited Consolidated Earnings Guidance for the Year Ended 31 December 2023

Embry Holdings Limited Provides Unaudited Consolidated Earnings Guidance for the Year Ended 31 December 2022

Embry Holdings Limited Provides Sales Guidance for the Full Year Ending 31 December 2022

Embry Holdings Limited Provides Profit Guidance for Six Months Ended 30 June 2021

Embry Holdings Limited Provides Earnings Guidance for the Year Ended December of 2021

Embry Holdings Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended June 30, 2021

Recent updates

Benign Growth For Embry Holdings Limited (HKG:1388) Underpins Its Share Price

First half 2024 earnings released: HK$0.20 loss per share (vs HK$0.013 profit in 1H 2023)

Embry Holdings Limited to Report First Half, 2024 Results on Aug 28, 2024

Full year 2023 earnings released: HK$0.17 loss per share (vs HK$0.12 loss in FY 2022)

Embry Holdings Limited, Annual General Meeting, May 23, 2024

Full year 2023 earnings released: HK$0.17 loss per share (vs HK$0.12 loss in FY 2022)

Embry Holdings Limited to Report Fiscal Year 2023 Results on Mar 21, 2024

Improved Revenues Required Before Embry Holdings Limited (HKG:1388) Shares Find Their Feet

Embry Holdings Limited Provides Unaudited Consolidated Earnings Guidance for the Year Ended 31 December 2023

First half 2023 earnings released: EPS: HK$0.013 (vs HK$0.003 in 1H 2022)

Embry Holdings Limited to Report First Half, 2023 Results on Aug 24, 2023

Embry Holdings Appoints Mr. Chan Chi on as Director

Full year 2022 earnings released: HK$0.12 loss per share (vs HK$0.065 loss in FY 2021)

Embry Holdings Limited Provides Unaudited Consolidated Earnings Guidance for the Year Ended 31 December 2022

Less than half of directors are independent

Embry Holdings Limited Provides Sales Guidance for the Full Year Ending 31 December 2022

Does Embry Holdings (HKG:1388) Have A Healthy Balance Sheet?

First half 2022 earnings released: EPS: HK$0.003 (vs HK$0.078 in 1H 2021)

Embry Holdings Limited Provides Profit Guidance for Six Months Ended 30 June 2021

Less than half of directors are independent

Embry Holdings Limited Provides Earnings Guidance for the Year Ended December of 2021

Embry Holdings Limited Announces Resignation of Mr. Cheng Man Tai as Executive Director and Chairman, Effective 1 February 2022

Upcoming dividend of HK$0.02 per share

First half 2021 earnings released: EPS HK$0.078 (vs HK$0.092 loss in 1H 2020)

Embry Holdings Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended June 30, 2021

Capital Allocation Trends At Embry Holdings (HKG:1388) Aren't Ideal

Embry Holdings Limited Approves Final Dividend for the Year Ended 31 December 2020

Upcoming dividend of HK$0.025 per share

Embry Holdings Limited Provides Group Financial Guidance for the First Quarter Ended 31 March 2021

Full year 2020 earnings released: HK$0.007 loss per share (vs HK$0.19 profit in FY 2019)

Looking For Steady Income For Your Dividend Portfolio? Is Embry Holdings Limited (HKG:1388) A Good Fit?

Embry Holdings Limited Proposes Final Dividend, Payable on 10 June 2021

Full year 2020 earnings released: HK$0.007 loss per share (vs HK$0.19 profit in FY 2019)

Embry Holdings Limited to Report Fiscal Year 2020 Final Results on Mar 18, 2021

New 90-day high: HK$1.11

Our Take On The Returns On Capital At Embry Holdings (HKG:1388)

New 90-day high: HK$1.05

Would Shareholders Who Purchased Embry Holdings' (HKG:1388) Stock Five Years Be Happy With The Share price Today?

Our Take On The Returns On Capital At Embry Holdings (HKG:1388)

New 90-day low: HK$0.99

New 90-day low: HK$1.00

First half earnings released

Earnings released

Embry Holdings Limited to Report First Half, 2020 Results on Aug 20, 2020

業績と収益の成長予測

アナリストによる今後の成長予測

一株当たり利益成長率予想

将来の株主資本利益率

成長企業の発掘